---
$id: https://graph.org.ai/products/commodity/51372501
$type: Product
source: UNSPSC
code: "51372501"
title: "Metheptazine"
class: "51372500"
classTitle: "Controlled substance analgesics, synthesized"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metheptazine

**UNSPSC Code**: 51372501
**Class**: [Controlled substance analgesics, synthesized](Controlled substance analgesics, synthesized.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C16H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93X4R66P5A, chemically known as methyl 1,2-dimethyl-4-phenyl-4-azepanylcarboxylat but generally known as metheptazine, which bears US NIH Compound Identifier 3047717. European Medicines Agency schedules Metheptazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08846MIG. The term METHEPTAZINE is an International Non-Proprietary Name. METHEPTAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metheptazine under HS 29339930 and SITC 51577. As of Q4 2014, METHEPTAZINE remains the US FDA Preferred Term for this commodity. Metheptazine bears US NLM identifiers UMLS ID C2984000 and NCI Concept Code C91046. SMILES: O(C(=O)C1(CC(N(CCC1)C)C)C1CCCCC1)C.

